tradingkey.logo

Humana Inc

HUM
259.340USD
-1.330-0.51%
Cierre 12/19, 16:00ETCotizaciones retrasadas 15 min
31.19BCap. mercado
24.19P/E TTM

Más Datos de Humana Inc Compañía

Humana Inc. provides Humana insurance services and CenterWell health care services. The Company's segments include Insurance and CenterWell. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as its contract with CMS to administer the Limited Income Newly Eligible Transition (LI-NET) prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits. This segment also includes products consisting of employer group commercial fully-insured medical and specialty health insurance benefits marketed to individuals and employer groups. The CenterWell segment includes its pharmacy, primary care, and home solutions operations. The segment also includes its strategic partnerships with WCAS to develop and operate senior-focused, payor-agnostic, primary care centers, as well as its minority ownership interest in hospice operations.

Información de Humana Inc

Símbolo de cotizaciónHUM
Nombre de la empresaHumana Inc
Fecha de salida a bolsaMay 18, 1971
Director ejecutivoRechtin (James A)
Número de empleados65680
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 18
Dirección500 W Main St
CiudadLOUISVILLE
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal40202
Teléfono15025801000
Sitio Webhttps://www.humana.com/
Símbolo de cotizaciónHUM
Fecha de salida a bolsaMay 18, 1971
Director ejecutivoRechtin (James A)

Ejecutivos de Humana Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Frank A. D'amelio
Mr. Frank A. D'amelio
Independent Director
Independent Director
20.63K
--
Mr. Kurt J. Hilzinger
Mr. Kurt J. Hilzinger
Independent Chairman of the Board
Independent Chairman of the Board
19.45K
--
Mr. Joseph Christopher (Joe) Ventura
Mr. Joseph Christopher (Joe) Ventura
Chief Legal Officer
Chief Legal Officer
17.32K
+48.83%
Dr. Vishal Agrawal, M.D.
Dr. Vishal Agrawal, M.D.
Chief Strategy and Corporate Development Officer
Chief Strategy and Corporate Development Officer
16.72K
+35.01%
Mr. Jorge S. Mesquita
Mr. Jorge S. Mesquita
Independent Director
Independent Director
2.58K
+55.96%
Mr. John W. Garratt
Mr. John W. Garratt
Independent Director
Independent Director
1.69K
+34.26%
Mr. Gordon A. Smith
Mr. Gordon A. Smith
Independent Director
Independent Director
765.00
--
Ms. Karen W. Katz
Ms. Karen W. Katz
Independent Director
Independent Director
590.00
--
Dr. David T. Feinberg, M.D.
Dr. David T. Feinberg, M.D.
Independent Director
Independent Director
441.00
--
Ms. Marcy S. Klevorn
Ms. Marcy S. Klevorn
Independent Director
Independent Director
436.00
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Frank A. D'amelio
Mr. Frank A. D'amelio
Independent Director
Independent Director
20.63K
--
Mr. Kurt J. Hilzinger
Mr. Kurt J. Hilzinger
Independent Chairman of the Board
Independent Chairman of the Board
19.45K
--
Mr. Joseph Christopher (Joe) Ventura
Mr. Joseph Christopher (Joe) Ventura
Chief Legal Officer
Chief Legal Officer
17.32K
+48.83%
Dr. Vishal Agrawal, M.D.
Dr. Vishal Agrawal, M.D.
Chief Strategy and Corporate Development Officer
Chief Strategy and Corporate Development Officer
16.72K
+35.01%
Mr. Jorge S. Mesquita
Mr. Jorge S. Mesquita
Independent Director
Independent Director
2.58K
+55.96%
Mr. John W. Garratt
Mr. John W. Garratt
Independent Director
Independent Director
1.69K
+34.26%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Premiums
30.72B
94.84%
Service
1.40B
4.32%
Investment income
272.00M
0.84%
La empresa aún no ha revelado los datos relevantes.
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Premiums
30.72B
94.84%
Service
1.40B
4.32%
Investment income
272.00M
0.84%

Estadísticas de accionistas

Actualizado: lun., 17 de nov
Actualizado: lun., 17 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
11.72%
Dodge & Cox
9.43%
BlackRock Institutional Trust Company, N.A.
5.24%
State Street Investment Management (US)
4.46%
Pzena Investment Management, LLC
3.35%
Otro
65.80%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
11.72%
Dodge & Cox
9.43%
BlackRock Institutional Trust Company, N.A.
5.24%
State Street Investment Management (US)
4.46%
Pzena Investment Management, LLC
3.35%
Otro
65.80%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
47.22%
Investment Advisor/Hedge Fund
36.65%
Hedge Fund
6.30%
Research Firm
2.54%
Bank and Trust
2.53%
Pension Fund
2.48%
Sovereign Wealth Fund
1.41%
Individual Investor
0.23%
Family Office
0.07%
Otro
0.59%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
2206
122.13M
101.55%
-4.23M
2025Q2
2257
114.76M
95.42%
-19.25M
2025Q1
2321
116.64M
96.64%
-15.71M
2024Q4
2306
118.51M
98.19%
-7.58M
2024Q3
2271
114.45M
95.04%
-13.07M
2024Q2
2270
116.19M
96.50%
-5.74M
2024Q1
2237
112.35M
93.21%
-8.14M
2023Q4
2219
114.70M
93.84%
-10.54M
2023Q3
2136
116.47M
94.60%
-6.57M
2023Q2
2114
117.98M
95.21%
-8.26M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
14.14M
11.76%
+223.18K
+1.60%
Jun 30, 2025
Dodge & Cox
11.35M
9.44%
+597.71K
+5.56%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
6.28M
5.22%
-328.94K
-4.97%
Jun 30, 2025
State Street Investment Management (US)
5.38M
4.47%
+58.09K
+1.09%
Jun 30, 2025
Pzena Investment Management, LLC
4.08M
3.39%
+247.74K
+6.47%
Jun 30, 2025
Eagle Capital Management L.L.C.
3.95M
3.28%
+806.19K
+25.65%
Jun 30, 2025
JP Morgan Asset Management
2.07M
1.72%
+143.67K
+7.48%
Jun 30, 2025
Geode Capital Management, L.L.C.
3.13M
2.6%
+57.27K
+1.86%
Jun 30, 2025
Fidelity Management & Research Company LLC
2.61M
2.17%
+518.01K
+24.72%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: mar., 2 de dic
Actualizado: mar., 2 de dic
Nombre
Proporción
iShares U.S. Healthcare Providers ETF
4.36%
Eagle Capital Select Equity ETF
3.26%
American Customer Satisfaction ETF
2.4%
State Street SPDR S&P Health Care Services ETF
2.07%
Invesco S&P 500 Pure Value ETF
1.79%
Invesco S&P 500 Equal Weight Health Care ETF
1.66%
Alpha Architect US Quantitative Value ETF
1.65%
SRH US Quality GARP ETF
1.65%
iShares Large Cap Active ETF
1.57%
JPMorgan Active Value ETF
1.54%
Ver más
iShares U.S. Healthcare Providers ETF
Proporción4.36%
Eagle Capital Select Equity ETF
Proporción3.26%
American Customer Satisfaction ETF
Proporción2.4%
State Street SPDR S&P Health Care Services ETF
Proporción2.07%
Invesco S&P 500 Pure Value ETF
Proporción1.79%
Invesco S&P 500 Equal Weight Health Care ETF
Proporción1.66%
Alpha Architect US Quantitative Value ETF
Proporción1.65%
SRH US Quality GARP ETF
Proporción1.65%
iShares Large Cap Active ETF
Proporción1.57%
JPMorgan Active Value ETF
Proporción1.54%

Dividendos

Un total de 1.93B USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Oct 28, 2025
HUM.NB Final Cash Dividend of gross USD 0.885 paid on Jan 30, 2026 going ex on Dec 26, 2025
Dec 26, 2025
Jan 30, 2026
Dec 26, 2025
Feb 20, 2025
HUM.NB Interim Cash Dividend of gross USD 0.885 paid on Apr 25, 2025 going ex on Mar 28, 2025
Mar 28, 2025
Apr 25, 2025
Mar 28, 2025
Oct 24, 2024
HUM.NB Final Cash Dividend of gross USD 0.885 paid on Jan 31, 2025 going ex on Dec 31, 2024
Dec 31, 2024
Jan 31, 2025
Dec 31, 2024
Aug 15, 2024
HUM.NB Interim Cash Dividend of gross USD 0.885 paid on Oct 25, 2024 going ex on Sep 30, 2024
Sep 30, 2024
Oct 25, 2024
Sep 30, 2024
Apr 18, 2024
HUM.NB Interim Cash Dividend of gross USD 0.885 paid on Jul 26, 2024 going ex on Jun 28, 2024
Jun 28, 2024
Jul 26, 2024
Jun 28, 2024
Feb 15, 2024
HUM.NB Interim Cash Dividend of gross USD 0.885 paid on Apr 26, 2024 going ex on Mar 27, 2024
Mar 29, 2024
Apr 26, 2024
Mar 27, 2024
Nov 02, 2023
HUM.NB Final Cash Dividend of gross USD 0.885 paid on Jan 26, 2024 going ex on Dec 28, 2023
Dec 29, 2023
Jan 26, 2024
Dec 28, 2023
Aug 17, 2023
HUM.NB Interim Cash Dividend of gross USD 0.885 paid on Oct 27, 2023 going ex on Sep 28, 2023
Sep 29, 2023
Oct 27, 2023
Sep 28, 2023
Apr 20, 2023
HUM.NB Interim Cash Dividend of gross USD 0.885 paid on Jul 28, 2023 going ex on Jun 29, 2023
Jun 30, 2023
Jul 28, 2023
Jun 29, 2023
Feb 16, 2023
HUM.NB Interim Cash Dividend of gross USD 0.885 paid on Apr 28, 2023 going ex on Mar 30, 2023
Mar 31, 2023
Apr 28, 2023
Mar 30, 2023
Ver más

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Humana Inc?

Los cinco principales accionistas de Humana Inc son:
The Vanguard Group, Inc. posee 14.14M acciones, lo que representa el 11.76% del total de acciones.
Dodge & Cox posee 11.35M acciones, lo que representa el 9.44% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 6.28M acciones, lo que representa el 5.22% del total de acciones.
State Street Investment Management (US) posee 5.38M acciones, lo que representa el 4.47% del total de acciones.
Pzena Investment Management, LLC posee 4.08M acciones, lo que representa el 3.39% del total de acciones.

¿Cuáles son los tres principales tipos de accionista de Humana Inc?

Los tres principales tipos de accionista de Humana Inc son:
The Vanguard Group, Inc.
Dodge & Cox
BlackRock Institutional Trust Company, N.A.

¿Cuántas instituciones poseen acciones de Humana Inc (HUM)?

A fecha de 2025Q3, 2206 instituciones poseen acciones de Humana Inc, con un valor de mercado combinado de aproximadamente 122.13M, lo que representa el 101.55% del total de acciones. En comparación con el 2025Q2, el accionariado institucional ha aumentado en 6.13%.

¿Cuál es la mayor fuente de ganancias de Humana Inc?

El FY2025Q2, el segmento empresarial Premiums generó la ganancia más alta para Humana Inc, ascendiendo a 30.72B y representando el 94.84% de la ganancia total.
KeyAI